Muhamad Amza Ali
Founder bei Psyence Therapeutics Corp.
Profil
Muhamad Amza Ali is the founder and Chief Medical Officer of Psyence Therapeutics Corp.
which is founded in 2020.
He is currently the Head of Neurosciences Research at The University of the West Indies since 2016 and also serves as the President of the Caribbean Chapter at the International League Against Epilepsy.
Dr. Ali was the Director and Chief Medical Officer at Psyence Group, Inc. from 2021 to 2022 and was the Chief Medical Officer at Avicanna, Inc. from 2019 to 2021.
He holds an MBA from Rotman School of Management (2016), a graduate degree from Henley Business School Ltd.
(2017), and an undergraduate degree from The University of the West Indies (1984).
Aktive Positionen von Muhamad Amza Ali
| Unternehmen | Position | Beginn |
|---|---|---|
| International League Against Epilepsy | Corporate Officer/Principal | - |
| Psyence Therapeutics Corp. | Founder | 01.04.2020 |
| The University of the West Indies | Corporate Officer/Principal | 01.09.2016 |
Ehemalige bekannte Positionen von Muhamad Amza Ali
| Unternehmen | Position | Ende |
|---|---|---|
| PSYENCE GROUP INC. | Chief Tech/Sci/R&D Officer | 01.09.2022 |
| AVICANNA INC. | Chief Tech/Sci/R&D Officer | 01.01.2021 |
Ausbildung von Muhamad Amza Ali
| Rotman School of Management | Masters Business Admin |
| Henley Business School Ltd. | Graduate Degree |
| The University of the West Indies | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AVICANNA INC. | Health Technology |
| PSYENCE GROUP INC. | Industrial Services |
| Private Unternehmen | 2 |
|---|---|
| International League Against Epilepsy | |
| Psyence Therapeutics Corp. |
